Numerous kinds of genetic mutations had been investigated, and the KRAS, BRAF, TP53, SMAD, and p 16 (INK4) mutations are well known factors for cholangiocarcinoma pathogenesis. This evidence concerns the gene CDKN2A and cholangiocarcinoma.